CA125/MUC16 Antibody (986811) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB56091P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunohistochemistry
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 986811
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant human CA125/MUC-16
Met13360-Gln14347 (Met13472Thr & Gln13957Lys)
Accession # NP_078966.2
Met13360-Gln14347 (Met13472Thr & Gln13957Lys)
Accession # NP_078966.2
Specificity
Detects human CA125/MUC-16 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for CA125/MUC16 Antibody (986811) [PE]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from ascites
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CA125/MUC16
Long Name
Ovarian Cancer Antigen CA125
Alternate Names
MUC16
Additional CA125/MUC16 Products
Product Documents for CA125/MUC16 Antibody (986811) [PE]
Product Specific Notices for CA125/MUC16 Antibody (986811) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...